The Uromigos

401 Episoder

1. Episode 102: Adjuvant therapy in melanoma - how it will help inform the renal community

   Publisert: 28.5.2021
2. Episode 101: The Uromigos Paper of the Month - Belzutifan in renal cancer

   Publisert: 26.5.2021
3. Episode 100: The Uromigos 100th Podcast - Looking to the Future

   Publisert: 21.5.2021
4. Episode 99: Navigating social media from a patients' perspective

   Publisert: 19.5.2021
5. Episode 98: Bladder cancer from a patient perspective

   Publisert: 19.5.2021
6. Episode 97: Sacituzumab Govitecan in Bladder Cancer

   Publisert: 4.5.2021
7. Episode 96: ODAC Bladder Cancer Accelerated Approval Meetings with Andrea Apolo

   Publisert: 28.4.2021
8. Episode 95: ODAC Overview and Bladder Accelerated Approval Meetings with Jorge Garcia

   Publisert: 28.4.2021
9. Episode 94: EIKCS Summary of Day 1

   Publisert: 23.4.2021
10. Episode 93: The Uromigos Paper of the Month - A new risk classification for germ cell cancer

    Publisert: 14.4.2021
11. Episode 92: Second line therapy in advanced RCC

    Publisert: 9.4.2021
12. Episode 91: The Uromigos Paper of the Month - Adjuvant atezolizumab in bladder cancer

    Publisert: 26.3.2021
13. Episode 90: The Uromigos Podcast with QOL Expert David Cella

    Publisert: 12.3.2021
14. Episode 89: The Uromigos Paper of the Month - Pembrolizumab in clear cell and non-clear cell renal cancer

    Publisert: 4.3.2021
15. Episode 88: Career Development in Academic Oncology Part 3 - Walter Stadler

    Publisert: 26.2.2021
16. Episode 87: Career Development in Academic Oncology Part 2 - Monty Pal

    Publisert: 26.2.2021
17. Episode 86: Career Development in Academic Oncology Part 1 - Moshe Ornstein

    Publisert: 26.2.2021
18. Episode 85: The CLEAR Trial

    Publisert: 14.2.2021
19. Episode 84: Prostate cancer highlights from ASCO #GU21 with Chris Sweeney

    Publisert: 13.2.2021
20. Episode 82: Which is the best VEGF/immune combination for first line metastatic renal cancer?

    Publisert: 13.2.2021